Home
Dashboard
Curated content
Startups & Scaleups
Corporates
Investors
Funding rounds
Exits
Accelerators
Workspaces
Universities
Service providers
More organizations
Matching tool
Investment heatmap
Themes
News
Companies
Sonoma Biotherapeutics
Save
Sonoma Biotherapeutics
Best-in-class regulatory T cell therapy, delivering long-lasting, highly effective, curative treatments across a spectrum of autoimmune and degenerative diseases.
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
Recent News about Sonoma Biotherapeutics
Edit